Cargando…
Letter to the editor regarding the study “The effectiveness of gabapentin and gabapentin/montelukast combination compared with dextromethorphan in the improvement of COVID‐19‐related cough: A randomized, controlled clinical trial”
Autores principales: | Ito, Shun, Shimamura, Yushi, Matsumoto, Hirotaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9877896/ https://www.ncbi.nlm.nih.gov/pubmed/36451291 http://dx.doi.org/10.1111/crj.13566 |
Ejemplares similares
-
Reply to the letter to the editor regarding the study “The effectiveness of gabapentin and gabapentin/montelukast combination compared with dextromethorphan in the improvement of COVID‐19‐related cough: A randomized, controlled clinical trial”
por: Hakamifard, Atousa, et al.
Publicado: (2023) -
The effectiveness of gabapentin and gabapentin/montelukast combination compared with dextromethorphan in the improvement of COVID‐19‐ related cough: A randomized, controlled clinical trial
por: Soltani, Rasool, et al.
Publicado: (2022) -
Letter to the Editor regarding Meta-analysis of the efficacy of gabapentin: a response
por: Masoud, Ahmed Taher, et al.
Publicado: (2022) -
Gabapentin for Chronic Refractory Cancer Cough
por: Atreya, Shrikant, et al.
Publicado: (2016) -
Letter to the editor regarding systematic review and meta-analysis of the efficacy of gabapentin in chronic female pelvic pain without another diagnosis
por: Vincent, Katy, et al.
Publicado: (2022)